Quick Answer
Chemomab Therapeutics Ltd. reported Earnings Per Share Diluted of $0.02 per share for the year ending 2025.
- Chemomab Therapeutics Ltd. showed a decrease of -53.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Chemomab Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Chemomab Therapeutics Ltd.'s Earnings Per Share Diluted has declined by 70.0%.
- Historical annual values: Fiscal year 2025: $0.02 per share | Fiscal year 2024: $0.04 per share | Fiscal year 2023: $0.10 per share | Fiscal year 2022: $0.12 per share | Fiscal year 2021: $0.06 per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: